Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
-
2024 WS
Vergangene Veranstaltungen (max. 10)
-
2024 SS
-
2023 WS
-
2023 SS
-
2022 WS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Agreement between local and central anti-synthetase antibodies detection : results from the Classification Criteria of Anti-Synthetase Syndrome project biobankIn: Clinical and Experimental Rheumatology Jg. 42 (2024) Nr. 2, S. 277 - 287Online Volltext: dx.doi.org/ (Open Access)
-
Automated 3D-Body Composition Analysis as a Predictor of Survival in Patients with Idiopathic Pulmonary FibrosisIn: Journal of Thoracic Imaging (2024) in pressOnline Volltext: dx.doi.org/ (Open Access)
-
CT-based body composition analysis and pulmonary fat attenuation volume as biomarkers to predict overall survival in patients with non-specific interstitial pneumoniaIn: European Radiology Experimental Jg. 8 (2024) Nr. 1, 114Online Volltext: dx.doi.org/ (Open Access)
-
Diagnostik und Therapie der exogen-allergischen Alveolitis : S2k-Leitlinie der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. und der Deutschen Gesellschaft für Allergologie und klinische Immunologie e. V.In: Pneumologie (2024) in pressOnline Volltext: dx.doi.org/
-
Impact of Systemic Sclerosis-Associated Interstitial Lung Disease with and without Pulmonary Hypertension on Survival : A Large Cohort Study of the German Network for Systemic SclerosisIn: Chest Jg. 165 (2024) Nr. 1, S. 132 - 145Online Volltext: dx.doi.org/ (Open Access)
-
Kidney manifestations of sarcoidosisIn: Journal of Autoimmunity (2024) 103207 in pressOnline Volltext: dx.doi.org/ (Open Access)
-
Pathogenesis-driven treatment of primary pulmonary alveolar proteinosisIn: European Respiratory Review (ERR) Jg. 33 (2024) Nr. 173, 240064Online Volltext: dx.doi.org/ (Open Access)
-
Pharmacological Treatment of Idiopathic Pulmonary Fibrosis (Update) and Progressive Pulmonary Fibroses : S2k Guideline of the German Respiratory SocietyIn: Respiration: International Journal of Thoracic Medicine (2024) in pressOnline Volltext: dx.doi.org/ (Open Access)
-
Pharmacological Treatment of Idiopathic Pulmonary Fibrosis (Update) and Progressive Pulmonary Fibroses : S2k Guideline of the German Respiratory SocietyIn: Respiration: International Journal of Thoracic Medicine (2024) 540856 in pressOnline Volltext: dx.doi.org/ (Open Access)
-
Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary FibrosisIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 210 (2024) Nr. 4, S. 435 - 443Online Volltext: dx.doi.org/
-
Therapie der Sarkoidose : Ein Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP)In: Pneumologie Jg. 78 (2024) Nr. 3, S. 151 - 166Online Volltext: dx.doi.org/
-
Anti-acid therapy in SSc-associated interstitial lung disease : long-term outcomes from the German Network for Systemic SclerosisIn: Rheumatology Jg. 62 (2023) Nr. 9, S. 3067 - 3074Online Volltext: dx.doi.org/ (Open Access)
-
COVID-19 in patients with pulmonary alveolar proteinosis : A European multicentre studyIn: ERJ Open Research Jg. 9 (2023) Nr. 1, 00199-2022Online Volltext: dx.doi.org/ (Open Access)
-
Comment on: Anti-acid therapy in SSc-associated interstitial lung disease : Long-term outcomes from the German Network for Systemic Sclerosis-caution is key in interpreting retrospective data: ReplyIn: Rheumatology Jg. 62 (2023) Nr. 12, S. e351 - e352Online Volltext: dx.doi.org/
-
Current and Future Treatment Landscape for Idiopathic Pulmonary FibrosisIn: Drugs Jg. 83 (2023) Nr. 17, S. 1581 - 1593Online Volltext: dx.doi.org/ (Open Access)
-
Erratum : Pharmakotherapie der idiopathischen Lungenfibrose (ein Update) und anderer progredienter pulmonaler FibrosenIn: Pneumologie Jg. 77 (2023) Nr. 2, S. e1Online Volltext: dx.doi.org/
-
European Respiratory Society statement on familial pulmonary fibrosisIn: European Respiratory Journal (ERJ) Jg. 61 (2023) Nr. 3, 2201383Online Volltext: dx.doi.org/ (Open Access)
-
Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trialIn: European Respiratory Journal (ERJ) Jg. 62 (2023) Nr. 4,Online Volltext: dx.doi.org/ (Open Access)
-
Genetic and geographic influence on phenotypic variation in European sarcoidosis patientsIn: Frontiers in Medicine Jg. 10 (2023) 1218106Online Volltext: dx.doi.org/ (Open Access)
-
Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare VariantsIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 207 (2023) Nr. 9, S. 1194 - 1202Online Volltext: dx.doi.org/
-
Investigating significant health trends in progressive fibrosing interstitial lung disease (INSIGHTS-ILD) : Rationale, aims and design of a nationwide prospective registryIn: BMC Pulmonary Medicine Jg. 23 (2023) Nr. 1, 64Online Volltext: dx.doi.org/ (Open Access)
-
Krebs von den Lungen 6 (KL-6) is a novel diagnostic and prognostic biomarker in pleural mesotheliomaIn: Lung Cancer Jg. 185 (2023) 107360Online Volltext: dx.doi.org/
-
Lung cancer in patients with idiopathic pulmonary fibrosis : A retrospective multicentre study in EuropeIn: Respirology Jg. 28 (2023) Nr. 1, S. 56 - 65Online Volltext: dx.doi.org/
-
MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosisIn: Respirology Jg. 28 (2023) Nr. 5, S. 455 - 464Online Volltext: dx.doi.org/
-
Pharmakotherapie der idiopathischen Lungenfibrose (ein Update) und anderer progredienter pulmonaler Fibrosen : S2k-Leitline der Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e. V.In: Pneumologie Jg. 77 (2023) Nr. 2, S. 94 - 119Online Volltext: dx.doi.org/
-
Pulmonary alveolar proteinosis - current and future therapeutical strategiesIn: Current Opinion in Pulmonary Medicine Jg. 29 (2023) Nr. 5, S. 465 - 474Online Volltext: dx.doi.org/
-
S1-Leitlinie Interdisziplinäre Diagnostik interstitieller Lungenerkrankungen im ErwachsenenalterIn: Pneumologie Jg. 77 (2023) Nr. 5, S. 269 - 302Online Volltext: dx.doi.org/ (Open Access)
-
SARS-CoV-2-Infektion und interstitielle Lungenerkrankungen : Positionspapier der Deutschen Gesellschaft für Pneumologie und BeatmungsmedizinIn: Pneumologie Jg. 77 (2023) Nr. 3, S. 143 - 157Online Volltext: dx.doi.org/
-
Sarkoidose : Internationale versus deutsche Leitlinien zur Behandlung der SarkoidoseIn: Zeitschrift für Pneumologie Jg. 20 (2023) Nr. 6, S. 325 - 332Online Volltext: dx.doi.org/
-
Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung DiseaseIn: Journal of Clinical Medicine (JCM) Jg. 12 (2023) Nr. 3, 1173Online Volltext: dx.doi.org/ (Open Access)
-
Serum KL-6 as a Candidate Predictor of Outcome in Patients with SARS-CoV-2 PneumoniaIn: Journal of Clinical Medicine (JCM) Jg. 12 (2023) Nr. 21, 6772Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Thoracic pain in patients with chronic interstitial lung disease : an underestimated symptomIn: Frontiers in Medicine Jg. 10 (2023) 1147555Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
A New Tool to Assess Quality of Life in Patients with Idiopathic Pulmonary Fibrosis or Non-specific Interstitial PneumoniaIn: Pneumologie Jg. 76 (2022) Nr. 01, S. 25 - 34Online Volltext: dx.doi.org/ (Open Access)
-
Communicating with patients with idiopathic pulmonary fibrosis : can we do it better?In: ERJ Open Research Jg. 8 (2022) Nr. 1, 00422-2021Online Volltext: dx.doi.org/ (Open Access)
-
Comparison of a 22G Crown-Cut Needle with a Conventional 22G Needle with EBUS Guidance in Diagnosis of SarcoidosisIn: Lung Jg. 200 (2022) Nr. 5, S. 633 - 641Online Volltext: dx.doi.org/ (Open Access)
-
Defining anti-synthetase syndrome: a systematic literature reviewIn: Clinical and Experimental Rheumatology Jg. 40 (2022) Nr. 2, S. 309 - 319Online Volltext: dx.doi.org/ (Open Access)
-
ERS International Congress 2021 : Highlights from the Interstitial Lung Diseases AssemblyIn: ERJ Open Research Jg. 8 (2022) Nr. 2, 640Online Volltext: dx.doi.org/ (Open Access)
-
Genetic testing in interstitial lung disease : An international surveyIn: Respirology Jg. 27 (2022) Nr. 9, S. 747 - 757Online Volltext: dx.doi.org/
-
IL-9 and IL-9 receptor expression in lymphocytes from bronchoalveolar lavage fluid of patients with interstitial lung diseaseIn: Immunobiology Jg. 227 (2022) Nr. 5, 152258Online Volltext: dx.doi.org/
-
Idiopathic pulmonary fibrosis : Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burdenIn: Respirology Jg. 27 (2022) Nr. 1, S. 66 - 75Online Volltext: dx.doi.org/ (Open Access)
-
Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis An International Working Group PerspectiveIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 206 (2022) Nr. 3, S. 247 - 259Online Volltext: dx.doi.org/
-
Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung DiseasesIn: Advances in Therapy Jg. 39 (2022) Nr. 7, S. 3392 - 3402Online Volltext: dx.doi.org/ (Open Access)
-
Predictors of mortality in subjects with progressive fibrosing interstitial lung diseasesIn: Respirology Jg. 27 (2022) Nr. 4, S. 294 - 300Online Volltext: dx.doi.org/ (Open Access)
-
Trial of a Phosphodiesterase 4 Inhibitor for Idiopathic Pulmonary FibrosisIn: The New England Journal of Medicine Jg. 387 (2022) Nr. 8, S. 761 - 762Online Volltext: dx.doi.org/ (Open Access)
-
Chest radiography or computed tomography for COVID-19 pneumonia? : Comparative study in a simulated triage settingIn: European Respiratory Journal (ERJ) Jg. 58 (2021) Nr. 3, 2004188Online Volltext: dx.doi.org/ (Open Access)
-
ERS clinical practice guidelines on treatment of sarcoidosisIn: European Respiratory Journal (ERJ) Jg. 58 (2021) Nr. 6, 2004079Online Volltext: dx.doi.org/ (Open Access)
-
Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbiditiesIn: Respiratory Research Jg. 22 (2021) Nr. 1, S. 125Online Volltext: dx.doi.org/ (Open Access)
-
Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)In: Annals of the Rheumatic Diseases (ARD) Jg. 80 (2021) Nr. 2, S. 143 - 150Online Volltext: dx.doi.org/ (Open Access)
-
Misconceptions regarding symptoms of sarcoidosisIn: The Lancet Respiratory Medicine Jg. 9 (2021) Nr. 8, S. 816 - 818Online Volltext: dx.doi.org/
-
Patient Reported Experiences and Delays During the Diagnostic Pathway for Pulmonary Fibrosis : A Multinational European SurveyIn: Frontiers in Medicine Jg. 8 (2021) 711194Online Volltext: dx.doi.org/ (Open Access)
-
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease : Where to go from here?In: European Respiratory Review (ERR) Jg. 30 (2021) Nr. 160, 210026Online Volltext: dx.doi.org/ (Open Access)
-
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF) : A double-blind, randomised, placebo-controlled, phase 2b trialIn: The Lancet Respiratory Medicine Jg. 9 (2021) Nr. 5, S. 476 - 486Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPFIn: Orphanet Journal of Rare Diseases Jg. 16 (2021) Nr. 1, 111Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
S2K Guideline for Diagnosis of Idiopathic Pulmonary FibrosisIn: Respiration: International Journal of Thoracic Medicine Jg. 100 (2021) Nr. 3, S. 238 - 271Online Volltext: dx.doi.org/ (Open Access)
-
Sprachliche Validierung des Fibrose-Fragebogens zur Erfassung der Lebensqualität bei Patienten mit idiopathischer Lungenfibrose und idiopathischer nichtspezifischer interstitieller PneumonieIn: Pneumologie Jg. 75 (2021) Nr. 10, S. 753 - 760Online Volltext: dx.doi.org/
-
The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey : international survey and call for consensusIn: ERJ Open Research Jg. 7 (2021) Nr. 1, S. 00529 - 02020Online Volltext: dx.doi.org/ (Open Access)
-
Unclassifiable, or simply unclassified interstitial lung disease?In: Current Opinion in Pulmonary Medicine Jg. 27 (2021) Nr. 5, S. 405 - 413Online Volltext: dx.doi.org/
-
Adiponectin and leptin levels in idiopathic pulmonary fibrosis : A new method for BAL and serum assessmentIn: Immunobiology Jg. 225 (2020) Nr. 5, 151997Online Volltext: dx.doi.org/
-
Azathioprine for Connective Tissue Disease-Associated Interstitial Lung DiseaseIn: Respiration: International Journal of Thoracic Medicine Jg. 99 (2020) Nr. 8, S. 628 - 636Online Volltext: dx.doi.org/
-
Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy : Increased rate and mimicker of metastasisIn: European Journal of Cancer (EJC) Jg. 131 (2020) S. 18 - 26Online Volltext: dx.doi.org/
-
Efficacy, safety, and tolerability of combined pirfenidone and N-acetylcysteine therapy : a systematic review and meta-analysisIn: BMC Pulmonary Medicine Jg. 20 (2020) S. 128Online Volltext: dx.doi.org/ (Open Access)
-
Ganzlungenlavage bei pulmonaler Alveolarproteinose - Schritt für SchrittIn: Pneumologie Jg. 74 (2020) Nr. 10, S. 660 - 664Online Volltext: dx.doi.org/
-
Genotype in MUC5B-Promoter Polymorphism and Chronic Lung Allograft Dysfunction (CLAD) in a German Cohort : Preliminary ResultsIn: The Journal of Heart and Lung Transplantation Jg. 39 (2020) Nr. 4, S. S305 - S306Online Volltext: dx.doi.org/
-
Hypersensitivity pneumonitisIn: Nature Reviews Disease Primers Jg. 6 (2020) Nr. 1, S. 65Online Volltext: dx.doi.org/
-
Inhaled molgramostim therapy in autoimmune pulmonary alveolar proteinosisIn: The New England Journal of Medicine Jg. 383 (2020) Nr. 17, S. 1635 - 1644Online Volltext: dx.doi.org/ (Open Access)
-
Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease : A comprehensive reviewIn: Biomarkers in Medicine Jg. 14 (2020) Nr. 8, S. 675 - 682Online Volltext: dx.doi.org/
-
Looking into the future of sarcoidosis : What is next for treatment?In: Current Opinion in Pulmonary Medicine Jg. 26 (2020) Nr. 5, S. 598 - 607Online Volltext: dx.doi.org/
-
S2K-Leitlinie zur Diagnostik der idiopathischen LungenfibroseIn: Pneumologie Jg. 74 (2020) Nr. 5, S. 263 - 293Online Volltext: dx.doi.org/
-
Serum KL-6 concentrations as a novel biomarker of severe COVID-19In: Journal of Medical Virology Jg. 92 (2020) Nr. 10, S. 2216 - 2220Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Shedding light on developmental drugs for idiopathic pulmonary fibrosisIn: Expert Opinion on Investigational Drugs Jg. 29 (2020) Nr. 8, S. 797 - 808Online Volltext: dx.doi.org/ (Open Access)
-
Therapie der systemischen Sklerose-assoziierten interstitiellen LungenerkrankungIn: Zeitschrift für Rheumatologie Jg. 79 (2020) Nr. 3, S. 294 - 303Online Volltext: dx.doi.org/ (Open Access)
-
Therapie von Komplikationen und nichtpharmakologisches Management der idiopathischen pulmonalen FibroseIn: Der Pneumologe Jg. 17 (2020) Nr. 3, S. 186 - 196Online Volltext: dx.doi.org/ (Open Access)
-
Baseline High-Resolution CT Findings Predict Acute Exacerbation of Idiopathic Pulmonary Fibrosis : German and Japanese Cohort StudyIn: Journal of Clinical Medicine (JCM) Jg. 8 (2019) Nr. 12, 2069Online Volltext: dx.doi.org/ (Open Access)
-
Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the TOMORROW and INPULSIS trialsIn: European Respiratory Journal (ERJ) Jg. 54 (2019) Nr. 3, S. 1801797Online Volltext: dx.doi.org/ (Open Access)
-
Changes in serum KL-6 levels are associated with the development of chronic lung allograft dysfunction in lung transplant recipientsIn: Transplant Immunology Jg. 52 (2019) S. 40 - 44Online Volltext: dx.doi.org/
-
Correction to: The burden of sarcoidosis symptoms from a patient perspectiveIn: Lung Jg. 197 (2019) Nr. 2, S. 163Online Volltext: dx.doi.org/ (Open Access)
-
Erratum zu: Differenzialdiagnose interstitieller Lungenerkrankungen – „Interstitial pneumonia with autoimmune features“ (IPAF)In: Der Pneumologe Jg. 16 (2019) Nr. 1, S. 39Online Volltext: dx.doi.org/ (Open Access)
-
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time CourseIn: Journal of Clinical Medicine (JCM) Jg. 8 (2019) Nr. 11, 2013Online Volltext: dx.doi.org/ (Open Access)
-
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations : Results of a multicenter international studyIn: The Journal of Rheumatology Jg. 46 (2019) Nr. 3, S. 279 - 284Online Volltext: dx.doi.org/ (Open Access)
-
Pulmonary alveolar proteinosisIn: Nature Reviews Disease Primers Jg. 5 (2019) Nr. 1, S. 16Online Volltext: dx.doi.org/
-
Quantitative lipidomics in pulmonary alveolar proteinosisIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 200 (2019) Nr. 7, S. 881 - 887Online Volltext: dx.doi.org/
-
Research highlights from the 2018 ERS International Congress : interstitial lung diseasesIn: ERJ Open Research Jg. 5 (2019) Nr. 1, S. 00215 - 02018Online Volltext: dx.doi.org/ (Open Access)
-
Shaping the future of an ultra-rare disease : unmet needs in the diagnosis and treatment of pulmonary alveolar proteinosisIn: Current Opinion in Pulmonary Medicine Jg. 25 (2019) Nr. 5, S. 450 - 458Online Volltext: dx.doi.org/
-
The Burden of Sarcoidosis Symptoms from a Patient PerspectiveIn: Lung Jg. 197 (2019) Nr. 2, S. 155 - 161Online Volltext: dx.doi.org/ (Open Access)
-
The characterisation of interstitial lung disease multidisciplinary team meetings : A global studyIn: ERJ Open Research Jg. 5 (2019) Nr. 2, S. 00209 - 02018Online Volltext: dx.doi.org/ (Open Access)
-
Utility of Anti-DSF70 Antibodies to Predict Connective Tissue Disease in Patients Originally Presenting with Idiopathic Interstitial PneumoniaIn: Respiration: International Journal of Thoracic Medicine Jg. 98 (2019) Nr. 1, S. 29 - 37Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Die „Rheumalunge“ in der Computertomographie : radiologische Manifestationen der rheumatoiden ArthritisIn: Der Pneumologe Jg. 15 (2018) Nr. 6, S. 419 - 427Online Volltext: dx.doi.org/
-
Differenzialdiagnose interstitieller LungenerkrankungenIn: Der Pneumologe Jg. 15 (2018) Nr. 6, S. 413 - 418Online Volltext: dx.doi.org/
-
European Respiratory Society International Congress 2017 : Highlights from the Clinical AssemblyIn: ERJ Open Research Jg. 4 (2018) Nr. 1, S. 00134 - 02017Online Volltext: dx.doi.org/ (Open Access)
-
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis : Uncertainties and ControversiesIn: Respiration: International Journal of Thoracic Medicine Jg. 96 (2018) Nr. 6, S. 571 - 587Online Volltext: dx.doi.org/
-
Metformin Does Not Affect Clinically Relevant Outcomes in Patients with Idiopathic Pulmonary FibrosisIn: Respiration: International Journal of Thoracic Medicine Jg. 96 (2018) Nr. 4, S. 314 - 322Online Volltext: dx.doi.org/ (Open Access)
-
Patientenfragebogen zur Erfassung der Ursachen interstitieller und seltener Lungenerkrankungen - klinische Sektion der DGPIn: Pneumologie Jg. 72 (2018) Nr. 6, S. 446 - 457Online Volltext: dx.doi.org/
-
Phenotypes of organ involvement in sarcoidosisIn: European Respiratory Journal (ERJ) Jg. 51 (2018) Nr. 1, S. 1700991Online Volltext: dx.doi.org/ (Open Access)
-
Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary FibrosisIn: Respiration: International Journal of Thoracic Medicine Jg. 95 (2018) Nr. 5, S. 317 - 326Online Volltext: dx.doi.org/ (Open Access)
-
Timing of onset affects arthritis presentation pattern in antisynthetase syndromeIn: Clinical and Experimental Rheumatology Jg. 36 (2018) Nr. 1, S. 44 - 49
-
Epidemiologie und klinisches Erscheinungsbild der SarkoidoseIn: Klinische Monatsblätter für Augenheilkunde Jg. 234 (2017) Nr. 6, S. 790 - 795Online Volltext: dx.doi.org/
-
Idiopathic pleuroparenchymal fibroelastosis (PPFE) : A case study of a rare entityIn: Revista Portuguesa de Pneumologia (English Edition) Jg. 23 (2017) Nr. 6, S. 352 - 355Online Volltext: dx.doi.org/ (Open Access)
-
Therapeutic targets in idiopathic pulmonary fibrosisIn: Respiratory Medicine Jg. 131 (2017) S. 49 - 57Online Volltext: dx.doi.org/
-
Facts and promises on lung biomarkers in interstitial lung diseasesIn: Expert Review of Respiratory Medicine Jg. 9 (2015) Nr. 4, S. 437 - 457Online Volltext: dx.doi.org/
-
Update on therapeutic management of idiopathic pulmonary fibrosisIn: Therapeutics and Clinical Risk Management Jg. 11 (2015) S. 359 - 370Online Volltext: dx.doi.org/ (Open Access)
-
Chronic Hypersensitivity PneumonitisIn: Clinics in Chest Medicine Jg. 33 (2012) Nr. 1, S. 151 - 163Online Volltext: dx.doi.org/
-
Diagnostic approach to interstitial pneumonias in a single centre : report on 88 casesIn: Diagnostic Pathology Jg. 7 (2012) S. 160Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Different MUC1 gene polymorphisms in German and Japanese ethnicities affect serum KL-6 levelsIn: Respiratory Medicine Jg. 106 (2012) Nr. 12, S. 1756 - 1764Online Volltext: dx.doi.org/
-
Hypersensitivity PneumonitisIn: Immunology and Allergy Clinics of North America Jg. 32 (2012) Nr. 4, S. 537 - 556Online Volltext: dx.doi.org/
-
KL-6, a Human MUC1 Mucin, as a prognostic marker for diffuse alveolar hemorrhage syndromeIn: Orphanet Journal of Rare Diseases Jg. 7 (2012) Nr. 1, S. 99Online Volltext: dx.doi.org/ (Open Access)
-
Wash-out kinetics and efficacy of a modified lavage technique for alveolar proteinosisIn: European Respiratory Journal (ERJ) Jg. 40 (2012) Nr. 6, S. 1468 - 1474Online Volltext: dx.doi.org/
-
Comparison of serum KL-6 versus bronchoalveolar lavage neutrophilia for the diagnosis of bronchiolitis obliterans in lung transplantationIn: The Journal of Heart and Lung Transplantation Jg. 30 (2011) Nr. 12, S. 1374 - 1380Online Volltext: dx.doi.org/
-
Lungensarkoidose : Diagnostik und TherapieIn: Gynäkologische Praxis Jg. 35 (2011) Nr. 3, S. 473 - 482
-
Lungensarkoidose : Diagnostik und TherapieIn: Tägliche Praxis Jg. 52 (2011) Nr. 3, S. 463 - 472
-
Pulmonary alveolar proteinosis : New insights from a single-center cohort of 70 patientsIn: Respiratory Medicine Jg. 105 (2011) Nr. 12, S. 1908 - 1916Online Volltext: dx.doi.org/
-
Surfactant protein D and KL-6 serum levels in systemic sclerosis: Correlation with lung and systemic involvementIn: Sarcoidosis Vasculitis and Diffuse Lung Diseases Jg. 28 (2011) Nr. 1, S. 27 - 33
-
Treatment of pulmonary fibrosis : New substances and new interventionsIn: Der Internist Jg. 52 (2011) Nr. 12, S. 1422 - 1428Online Volltext: dx.doi.org/
-
Angiogenic and angiostatic chemokines in idiopathic pulmonary fibrosis and granulomatous lung diseaseIn: Respiration: International Journal of Thoracic Medicine Jg. 80 (2010) Nr. 5, S. 372 - 378Online Volltext: dx.doi.org/ (Open Access)
-
Diagnostic modalities in sarcoidosis: BAL, EBUS, and PETIn: Seminars in Respiratory and Critical Care Medicine Jg. 31 (2010) Nr. 4, S. 404 - 408Online Volltext: dx.doi.org/
-
Will inhalational GM-CSF replace whole lung lavage as a treatment for autoimmune pulmonary alveolar proteinosis? : Many pole positions, not yet the final winnerIn: European Respiratory Journal (ERJ) Jg. 63 (2024) Nr. 1, 2301982Online Volltext: dx.doi.org/
-
Interstitielle LungenerkrankungenIn: Zeitschrift für Pneumologie Jg. 20 (2023) Nr. 6, S. 297 - 299Online Volltext: dx.doi.org/ (Open Access)
-
IntroductionIn: Sarcoidosis / Bonella, Francesco; Culver, Daniel A.; Israël-Biet, Dominique (Hrsg.) (2022) S. x - xiiiOnline Volltext: dx.doi.org/
-
Targeted therapy for pulmonary alveolar proteinosis: the time is nowIn: European Respiratory Journal (ERJ) Jg. 59 (2022) Nr. 4, 2102971Online Volltext: dx.doi.org/ (Open Access)
-
The perpetual enigma of bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis : Is it of diagnostic value?In: European Respiratory Journal (ERJ) Jg. 56 (2020) Nr. 2, S. 2001534Online Volltext: dx.doi.org/ (Open Access)
-
When the Game Changes : Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 PandemicIn: Chest Jg. 158 (2020) Nr. 3, S. 892 - 895Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Biomarkers extracted by fully automated body composition analysis (BCA) from chest CT in patients with non-specific interstitial pneumonia (NSIP) : correlation with survival
64. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin, 20.–23.03.2024, Mannheim, Germany,In: Pneumologie Jg. 78 (2024) Nr. Suppl. 1, S. S93Online Volltext: dx.doi.org/ -
Charakteristika und Behandlung von Patienten mit fibrosierender interstitieller Lungenerkrankung in der klinischen Praxis : INSIGHTS-ILD Register
64. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin, 20.–23. März 2024, Mannheim, Germany,In: Pneumologie Jg. 78 (2024) Nr. Suppl. 1, S. S75 - S76Online Volltext: dx.doi.org/ -
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) : An international case seriesIn: Journal of Neuroendocrinology Jg. 36 (2024) Nr. Suppl. 1, S. 123
-
Olipudase alfa enzyme replacement therapy reverses interstitial lung disease in adults with acid sphingomyelinase deficiency : Long-term pulmonary outcomes of the ASCEND trialIn: Molecular Genetics and Metabolism Jg. 141 (2024) Nr. 2, 108075Online Volltext: dx.doi.org/
-
Association of ORMDL3 Polymorphisms With Disease Outcomes and Severity in Patients With Pulmonary Alveolar Proteinosis (PAP)
American Thoracic Society 2023 International Conference, May 19-24, 2023, Washington, DC,In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 207 (2023) Nr. Supplement: A38, Advancing our Understanding and Treatment of ILD, A4275Online Volltext: dx.doi.org/ -
Biomarkers Extracted by Fully Automated Body Composition Analysis From Chest CT Correlate With Survival in Idiopathic Pulmonary Fibrosis (IPF)
American Thoracic Society 2023 International Conference, May 19-24, 2023, Washington, DC,In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 207 (2023) Nr. Supplement: A38, Advancing our Understanding and Treatment of ILD, A1500Online Volltext: dx.doi.org/ -
Circulating Biomarkers in Patients With Progressive Pulmonary Fibrosis: Data From the INBUILD Trial
American Thoracic Society 2023 International Conference, May 19-24, 2023, Washington, DC,In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 207 (2023) Nr. Supplement: A38, Advancing our Understanding and Treatment of ILD, A1112Online Volltext: dx.doi.org/ -
Continued Nintedanib Treatment in Patients with Progressive Pulmonary Fibrosis Related to Autoimmune Disease : Data from INBUILD- ONIn: Arthritis & Rheumatism Jg. 75 (2023) Nr. Suppl. 9, S. 4260 - 4262Online Volltext: dx.doi.org/
-
Die Etablierung einer durchflusszytometrischen Multiparameter-Analyse der BAL und ihre Validierung durch Korrelation mit den Befunden der lichtmikroskopischen Routinediagnostik
63. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.,In: Pneumologie Jg. 77 (2023) Nr. S 01, S. S85 - S86Online Volltext: dx.doi.org/ -
Die Komplexizität der Diagnostik pulmonaler kavernöser Prozesse : Ein pneumologisch – rheumatolgischer Fallbericht
63. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.,In: Pneumologie Jg. 77 (2023) Nr. S 01, S. 86 - S87Online Volltext: dx.doi.org/ -
Die durchflusszytometrische Analyse von T-Lymphozytensubpopulationen in der bronchoalveolären Lavage (BAL) bei interstitiellen Lungenerkrankungen
63. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.,In: Pneumologie Jg. 77 (2023) Nr. S 01, S. S86Online Volltext: dx.doi.org/ -
Effects of Nintedanib on Circulating Biomarkers in Patients With Progressive Pulmonary Fibrosis : Subgroup Analyses of the INBUILD Trial
American Thoracic Society 2023 International Conference, May 19-24, 2023, Washington, DC,In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 207 (2023) A1128 Supplement: A38, Advancing our Understanding and Treatment of ILDOnline Volltext: dx.doi.org/ -
Effects of nintedanib on circulating biomarkers in patients with progressive fibrosing autoimmune disease-related interstitial lung diseases
European Congress of Rheumatology (EULAR); MAY 31-JUN 03, 2023; Milan, ITALY,In: Annals of the Rheumatic Diseases (ARD) Jg. 82 (2023) Nr. Suppl. 1, S. 722 - 722Online Volltext: dx.doi.org/ (Open Access) -
KL-6 is a potential diagnostic biomarker for pleural mesothelioma
63. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.,In: Pneumologie Jg. 77 (2023) Nr. S 01, S. S106 - S107Online Volltext: dx.doi.org/ -
Progrediente Pulmonale Fibrose (PPF) bei Patienten mit exogen allergischer Alveolitis
63. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.,In: Pneumologie Jg. 77 (2023) Nr. S 01, S. S102Online Volltext: dx.doi.org/ -
Prospektive randomisierte Studie zum Vergleich zweier Methoden der transbronchialen Kryobiopsie bei interstitiellen Lungenerkrankungen
63. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.,In: Pneumologie Jg. 77 (2023) Nr. S 01, S. S49Online Volltext: dx.doi.org/ -
Reversal of interstitial lung disease after olipudase alfa enzyme replacement therapy in adults with acid sphingomyelinase deficiency
International Congress of the European Respiratory Society (ERS) 2023 ; 9 - 13 September 2023, Milan, Italy,In: European Respiratory Journal (ERJ) Jg. 62 (2023) Nr. Supplement 67: ERS International Congress 2023 abstracts, OA3281Online Volltext: dx.doi.org/ -
Association of mUC5B rs35705950 minor allele with age and survival in European patients with Idiopathic Pulmonary FibrosisIn: European Respiratory Journal (ERJ) Jg. 60 (2022) Nr. 66, 1044Online Volltext: dx.doi.org/
-
COVID-19 in patients with Pulmonary Alveolar Proteinosis : A European multicenter study
ERS International Congress 2022 ; 4-6 September 2022, Barcelona, Spain and online,In: European Respiratory Journal (ERJ) Jg. 60 (2022) Nr. Supplement 66,Online Volltext: dx.doi.org/ -
Cellular activities of factor XII in lung fibrosis
62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.; 25.–28.05.2022; Leipzig,In: Pneumologie Jg. 76 (2022) Nr. Supplement 1, S. S42Online Volltext: dx.doi.org/ -
Comparison of a new Punch Needle with a conventional 22-gauge Needle in EBUS-TBNA in Patients with suspected Sarcoidosis
62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.; 25.–28.05.2022; Leipzig,In: Pneumologie Jg. 76 (2022) Nr. Supplement 1, S. S44Online Volltext: dx.doi.org/ -
Continued improvement in pulmonary outcomes in 3 clinical trials of olipudase alfa in children and adults with chronic acid sphingomyelinase deficiency treated for 2 to 6.5 years
WORLDSymposiumTM 2022, 07.-11.02.2022, Virtual,In: Molecular Genetics and Metabolism Jg. 135 (2022) Nr. 2, S. S108Online Volltext: dx.doi.org/ -
Continued nintedanib treatment in patients with progressive fibrosing ILDs : Interim analysis of INBUILD-ONIn: European Respiratory Journal (ERJ) Jg. 60 (2022) Nr. 66, 604Online Volltext: dx.doi.org/
-
Effects of Nintedanib on Circulating Biomarkers in Subjects with Progressive Fibrosing Interstitial Lung Diseases (ILDs)
International Conference of the American Thoracic Society (ATS) 2022 ; May 13-18, 2022, San Francisco, CA, USA,In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 205 (2022) Nr. Supplement, A3520Online Volltext: dx.doi.org/ -
Immune Checkpoint Inhibitor (ICI)-associated Pulmonary Manifestations (ICI-LM): Characterization of HRCT and BAL Findings
62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.; 25.–28.05.2022; Leipzig,In: Pneumologie Jg. 76 (2022) Nr. Supplement 1, S. S52Online Volltext: dx.doi.org/ -
Nintedanib in patients with progressive fibrosing ILDs in subgroups by comorbidity burdenIn: European Respiratory Journal (ERJ) Jg. 60 (2022) Nr. 66, 615Online Volltext: dx.doi.org/
-
ORMDL3 gene polymorphisms in patients with pulmonary alveolar proteinosis (PAP) and interstitial lung diseases (ILDs) : preliminary results
62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.; 25.–28.05.2022; Leipzig,In: Pneumologie Jg. 76 (2022) Nr. Supplement 1, S. S56Online Volltext: dx.doi.org/ -
Safety and tolerability of inhaled molgramostim in autoimmune pulmonary alveolar proteinosis (aPAP)
ERS International Congress ; 4-6 September 2022, Barcelona, Spain and online,In: European Respiratory Journal (ERJ) Jg. 60 (2022) Nr. Supplement 66,Online Volltext: dx.doi.org/ -
Serum KL-6 improves prediction of progressive phenotype (PP) at one year independently of underlying interstitial lung disease (ILD) : Results from the VAMOS studyIn: European Respiratory Journal (ERJ) Jg. 60 (2022) Nr. 66, 1274Online Volltext: dx.doi.org/
-
Sustained Improvement of Interstitial Lung Disease Following Enzyme Replacement Therapy with Olipudase Alfa in Children and Adults with Chronic Acid Sphingomyelinase Deficiency
International Conference of the American Thoracic Society (ATS) 2022 ; May 13-18, 2022, San Francisco, CA, USA,In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 205 (2022) Nr. Supplement, A5319Online Volltext: dx.doi.org/ -
Bronchoalveolar lavage fluid (BALF) findings in patients with immune checkpoint inhibitor (ICI)-associated interstitial pneumonia (IP)In: European Respiratory Journal (ERJ) (2021) OA4240Online Volltext: dx.doi.org/
-
Changes in Imaging Markers in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) Treated with Nintedanib : Sub-Study of the SENSCIS TrialIn: Pneumologie Jg. 75 (2021) Nr. Suppl. 1, 61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V., 02.–05.06.2021, Leipzig digital, S. S24 - S25Online Volltext: dx.doi.org/
-
Comparison of a 22G crown-cut needle with a conventional 22G needle with EBUS guidance in diagnosis of sarcoidosisIn: European Respiratory Journal (ERJ) Jg. 58 (2021) Nr. Suppl. 65, PA2454Online Volltext: dx.doi.org/
-
Consistent effect of nintedanib on reducing FVC decline across interstitial lung diseases (ILDs)
61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V., 02.–05.06.2021, Leipzig digital,In: Pneumologie Jg. 75 (2021) Nr. Suppl. 1, S. S25 - S26Online Volltext: dx.doi.org/ -
Continued Treatment with Nintedanib in Patients with Progressive Fibrosing Autoimmune Disease-Related Interstitial Lung Diseases : Data from INBUILD-ONIn: Arthritis & Rheumatology Jg. 73 (2021) Nr. Suppl. 9, S. 372 - 373
-
Continued nintedanib treatment in patients with progressive fibrosing ILDs: interim analysis of INBUILD-ONIn: European Respiratory Journal (ERJ) Jg. 58 (2021) Nr. Suppl. 65, PA2538Online Volltext: dx.doi.org/
-
Prevalence and quantification of thoracic pain (TP) through quantitative sensory testing (QST) in patients with chronic interstitial lung disease (cILD)In: European Respiratory Journal (ERJ) Jg. 58 (2021) Nr. Suppl. 65, PA2343Online Volltext: dx.doi.org/
-
Safety and tolerability of nintedanib in patients with fibrosing interstitial lung diseases : Pooled data from four trialsIn: European Respiratory Journal (ERJ) Jg. 58 (2021) Nr. Suppl. 65, PA2539Online Volltext: dx.doi.org/
-
Serum KL-6 as a biomarker to assess risk of worse outcome in patients with SARS-CoV2 infectionIn: European Respiratory Journal (ERJ) Jg. 58 (2021) Nr. Suppl. 65, PA655Online Volltext: dx.doi.org/
-
Berufliche bedingte EAA und die problematische Suche nach dem Auslöser
61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.; 25.–28.03.2020 (verschoben auf 2021); Leipzig,In: Pneumologie Jg. 74 (2020) Nr. Suppl. 1, S. S122Online Volltext: dx.doi.org/ -
Burden of idiopathic pulmonary fibrosis (IPF) on quality of life (QoL), work productivity, and healthcare useIn: European Respiratory Journal (ERJ) Jg. 23 (2020) Nr. Suppl. 2, S. 732Online Volltext: dx.doi.org/
-
Clinical burden of idiopathic pulmonary fibrosis (IPF) : physician and patient perceptionIn: European Respiratory Journal (ERJ) Jg. 56 (2020) Nr. Suppl. 64,Online Volltext: dx.doi.org/
-
Consistent effect of nintedanib on reducing FVC decline across interstitial lung diseases (ILDs)In: European Respiratory Journal (ERJ) Jg. 56 (2020) Nr. Suppl. 64,Online Volltext: dx.doi.org/
-
Cytokines, chemokines and growth factors concentration in BAL fluid from patients with Idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP)
ERS Virtual Congress 2020,In: European Respiratory Journal (ERJ) Jg. 56 (2020) Nr. Suppl. 64,Online Volltext: dx.doi.org/ -
Cytokines, chemokines and growth factors concentration in BAL fluid from patients with idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP)
61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.; 25.–28.03.2020 (verschoben auf 2021); Leipzig,In: Pneumologie Jg. 74 (2020) Nr. Suppl. 1, S. S90 - S91Online Volltext: dx.doi.org/ -
Does anti-acid treatment influence disease progression in systemic sclerosis interstitial lung disease (SSC-ILD)? : Data from the german SSC-networkIn: Annals of the Rheumatic Diseases (ARD) Jg. 79 (2020) Nr. Suppl. 1, S. 1585Online Volltext: dx.doi.org/
-
Effects of nintedanib in patients with IPF : subgroup analysis by Charlson Comorbidity Index (CCI)In: European Respiratory Journal (ERJ) Jg. 56 (2020) Nr. Suppl. 64,Online Volltext: dx.doi.org/
-
Effects of nintedanib in patients with progressive fibrosing ILDs and differing baseline FVC : further analyses of the INBUILD trialIn: European Respiratory Journal (ERJ) Jg. 56 (2020) Nr. Suppl. 64,Online Volltext: dx.doi.org/
-
Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Multiple ComorbiditiesIn: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 201 (2020) S. A4549Online Volltext: dx.doi.org/
-
Efficacy and safety of nintedanib in the elderly patient with IPF
61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.; 25.–28.03.2020 (verschoben auf 2021); Leipzig,In: Pneumologie Jg. 74 (2020) Nr. Suppl. 1, S. S100Online Volltext: dx.doi.org/ -
Gene Expression Profiling in Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Nintedanib and Sildenafil : Data from the INSTAGE Trial
ATS 2020 International Conference, 15.-20. Mai 2020, Philadelphia, USA - abgesagt,In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 201 (2020) S. A4049Online Volltext: dx.doi.org/ -
Idiopathic pulmonary fibrosis (IPF) : the patient journeyIn: European Respiratory Journal (ERJ) Jg. 56 (2020) Nr. Suppl. 64,Online Volltext: dx.doi.org/
-
Klinische Nutzbarkeit eines mit Serum KL-6 modifizierten GAP-Indexes bei Patienten mit interstitiellen Lungenerkrankungen (ILD)
61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.; 25.–28.03.2020 (verschoben auf 2021); Leipzig,In: Pneumologie Jg. 74 (2020) Nr. Suppl. 1, S. S10Online Volltext: dx.doi.org/ -
Monounsaturated Fatty Acid diet associates less gastrointestinal adverse events of pirfenidone : phase IV clinical trialIn: European Respiratory Journal (ERJ) Jg. 56 (2020) Nr. Suppl. 64,Online Volltext: dx.doi.org/
-
Potential Clinical Utility of Serum KL-6 for Improving the GAP-Staging in Patients with Interstitial Lung Diseases (ILD)
ATS 2020 International Conference, 15.-20. Mai 2020, Philadelphia, USA - abgesagt,In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 201 (2020) S. A4037Online Volltext: dx.doi.org/ -
The DIAMORFOSIS (Diagnosis and Management of Lung Cancer and Fibrosis) Survey
ATS 2020 International Conference, 15.-20. Mai 2020, Philadelphia, USA - abgesagt,In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 201 (2020) S. A2579Online Volltext: dx.doi.org/ -
The Gender-Age-Physiology (GAP) Index enhanced with KL-6 serum level for predicting disease progression in interstitial lung diseases (ILD)
ERS International Congress 2020,In: European Respiratory Journal (ERJ) Jg. 56 (2020) Nr. Suppl. 64,Online Volltext: dx.doi.org/ -
The INBUILD Trial of Nintedanib in Patients with Progressive Fibrosing Instititial Lung Diseases : Subgroup with Autoimmune Diseases
61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.; 25.–28. März 2020 (verschoben auf 2021); Leipzig,In: Pneumologie Jg. 74 (2020) Nr. Suppl. 1, S. S61 - S62Online Volltext: dx.doi.org/ -
Efficacy and safety of nintedanib in the elderly patient with IPFIn: European Respiratory Journal (ERJ) Jg. 54 (2019) Nr. Suppl. 63, S. PA1353Online Volltext: dx.doi.org/
-
Late Breaking Abstract - Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF)In: European Respiratory Journal (ERJ) Jg. 54 (2019) Nr. Suppl. 63, S. RCT1879Online Volltext: dx.doi.org/
-
Potential clinical utility of MUC5B and TOLLIP single nucleotide polymorphisms (SNP) in in the management of patients with IPFIn: European Respiratory Journal (ERJ) Jg. 54 (2019) Nr. Suppl. 63, S. PA5370Online Volltext: dx.doi.org/
-
Serum KL-6 as a biomarker for interstitial lung diseases in a clinical setting: application of a fully automated immunoassayIn: European Respiratory Journal (ERJ) Jg. 54 (2019) Nr. Suppl. 63, S. PA4697Online Volltext: dx.doi.org/
-
THU0339 Pulmonary Involvement and Outcome in Systemic Sclerosis (SSC) – ILD-PH as an Important SubsetIn: Annals of the Rheumatic Diseases (ARD) Jg. 78 (2019) Nr. Suppl. 2, S. 451Online Volltext: dx.doi.org/ (Open Access)
-
Cardiovascular safety of nintedanib in subgroups by baseline cardiovascular risk
Annual Scientific Meeting of the Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) ; 23–27 March 2018, Adelaide,In: Respirology Jg. 23 (2018) Nr. Suppl. 1, S. 101Online Volltext: dx.doi.org/ (Open Access) -
Clinical Relevance of Antinuclear Antibodies (ANA) in Patients with Hypersensitivity Pneumonitis (HP) : A Single Centre Experience
International Conference of the American Thoracic Society 2018 ; ATS 2018 ; May 18-23, 2018. San Diego,In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 197 (2018) Nr. 9, abstract issue, S. A3019 -
Predicted Versus Observed Mortality in Clinical Trials of Nintedanib in Idiopathic Pulmonary Fibrosis (IPF)
International Conference of the American Thoracic Society 2018 ; ATS 2018 ; May 18-23, 2018, San Diego,In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 197 (2018) Nr. 9, abstract issue, S. A2534 -
IgG4-related disease as an unexpected cause of hemoptysisIn: Rare and Interstitial Lung Diseases: Clinical Cases and Real-World Discussions 2025, S. 207 - 218Online Volltext: dx.doi.org/
-
Pulmonary alveolar microlithiasis : An ultra-rare diseaseIn: Rare and Interstitial Lung Diseases: Clinical Cases and Real-World Discussions 2024, S. 171 - 182Online Volltext: dx.doi.org/
-
BAL findings in interstitial lung diseaseIn: Bronchoalveolar Lavage in Basic Research and Clinical Medicine / Schildgen, Oliver; Schildgen, Verena; Brockmann, Michael (Hrsg.) 2023, S. 66 - 93Online Volltext: dx.doi.org/
-
Pulmonary sarcoidosisIn: Sarcoidosis / Bonella, Francesco; Culver, Daniel A.; Israël-Biet, Dominique (Hrsg.) 2022, S. 122 - 141Online Volltext: dx.doi.org/
-
Rare and Interstitial Lung Diseases : Clinical Cases and Real-World DiscussionsPhiladelphia (2024)Online Volltext: dx.doi.org/
-
SarcoidosisIn: European Respiratory Society Monograph Sheffield Jg. 96 (2022)Online Volltext: dx.doi.org/
-
Continued nintedanib treatment in patients with progressive pulmonary fibrosis : data from INBUILD-ON
64. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin, 20.–23. März 2024, Mannheim, Germany,In: Pneumologie Jg. 78 (2024) Nr. Suppl. 1, S. S79Online Volltext: dx.doi.org/ -
Die durchflusszytometrische Untersuchung von T-Lymphozytensubpopulationen in der Ganzlungen-Lavage (GLL) bei der pulmonalen Alveolarproteinose : eine Pilot-Studie
64. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin, 20.–23.03.2024, Mannheim, Germany,In: Pneumologie Jg. 78 (2024) Nr. Suppl. 1, S. S11 - S12Online Volltext: dx.doi.org/ -
Machine learned decision tree for diagnosis of ASMD among patients with unexplained ILD
64. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin, 20.–23. März 2024, Mannheim, Germany,In: Pneumologie Jg. 78 (2024) Nr. Suppl. 1, S. S84Online Volltext: dx.doi.org/ -
CT-derived biomarkers as predictors of overall survival in patients with idiopathic pulmonary fibrosis (IPF)
International Congress of the European Respiratory Society (ERS) 2023 ; 9 - 13 September 2023, Milan, Italy,In: European Respiratory Journal (ERJ) Jg. 62 (2023) Nr. Supplement 67: ERS International Congress 2023 abstracts, PA1131Online Volltext: dx.doi.org/ -
Continued nintedanib treatment in patients with progressive pulmonary fibrosis : data from INBUILD-ON
International Congress of the European Respiratory Society (ERS) 2023 ; 9 - 13 September 2023, Milan, Italy,In: European Respiratory Journal (ERJ) Jg. 62 (2023) Nr. Supplement 67: ERS International Congress 2023 abstracts, PA2874Online Volltext: dx.doi.org/ -
Effects of nintedanib on circulating biomarkers in patients with progressive pulmonary fibrosis : subgroups by fibrotic pattern on HRCT
International Congress of the European Respiratory Journal (ERS) 2023 ; 9 - 13 September 2023, Milan, Italy,In: European Respiratory Journal (ERJ) Jg. 62 (2023) Nr. Supplement 67: ERS International Congress 2023 abstracts, PA2879Online Volltext: dx.doi.org/ -
Efficacy and safety of nintedanib in elderly patients with progressive fibrosing interstitial lung diseases (ILDs)*
63. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V., 29.03 – 01.04.2023, Düsseldorf, Germany,In: Pneumologie Jg. 77 (2023) Nr. S 01, S. S57Online Volltext: dx.doi.org/ -
Flow cytometric evaluation of whole lung lavage (WLL) fluid from patients with pulmonary alveolar proteinosis (PAP) : preliminary findings
International Congress of the European Respiratory Society (ERS) 2023 ; 9 - 13 September 2023, Milan, Italy,In: European Respiratory Journal (ERJ) Jg. 62 (2023) Nr. Supplement 67: ERS International Congress 2023 abstracts, PA3946Online Volltext: dx.doi.org/ -
Increasing CRPM levels following antifibrotic therapy in IPF is associated with adverse outcomes with nintedanib, but not pirfenidone
International Congress of the European Respiratory Society (ERS) 2023 ; 9 - 13 September 2023, Milan, Italy,In: European Respiratory Journal (ERJ) Jg. 62 (2023) Nr. Supplement 67: ERS International Congress 2023 abstracts, PA1139Online Volltext: dx.doi.org/ -
Machine learned decision tree for diagnosis of ASMD among patients with unexplained ILD
International Congress of the European Respiratory Society (ERS) 2023 ; 9 - 13 September 2023, Milan, Italy,In: European Respiratory Journal (ERJ) Jg. 62 (2023) Nr. Supplement 67: ERS International Congress 2023 abstracts, PA3948Online Volltext: dx.doi.org/ -
Prognostic value of circulating biomarkers in patients with progressive pulmonary fibrosis
International Congress of the European Respiratory Society (ERS) 2023 ; 9 - 13 September 2023, Milan, Italy,In: European Respiratory Journal (ERJ) Jg. 62 (2023) Nr. Supplement 67: ERS International Congress 2023 abstracts, PA1132Online Volltext: dx.doi.org/ -
Progressive pulmonary fibrosis in patients with chronic hypersensitivity pneumonitis (cHP) : a single center experience
International Congress of the European Respiratory Society (ERS) 2023 ; 9 - 13 September 2023, Milan, Italy,In: European Respiratory Journal (ERJ) Jg. 62 (2023) Nr. Supplement 67: ERS International Congress 2023 abstracts, PA2883Online Volltext: dx.doi.org/ -
Continued nintedanib treatment in patients with progressive fibrosing ILDs : interim analysis of INBUILD-ON
62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.; 25.–28.05.2022; Leipzig,In: Pneumologie Jg. 76 (2022) Nr. Supplement 1, S. S25 - S26Online Volltext: dx.doi.org/ -
Effects of nintedanib in patients with idiopathic pulmonary fibrosis and varying severities of cough
62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.; 25.–28.05.2022; Leipzig,In: Pneumologie Jg. 76 (2022) Nr. Supplement 1, S. S20 - S21Online Volltext: dx.doi.org/ -
Efficacy and Safety of Nintedanib in Elderly Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs)
International Conference of the American Thoracic Society (ATS) 2022 ; May 13-18, 2022, San Francisco, CA, USA,In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 205 (2022) Nr. Supplement, A2426Online Volltext: dx.doi.org/ -
ORMDL3 Gene Polymorphisms in Patients with Pulmonary Alveolar Proteinosis (PAP) and Interstitial Lung Diseases (ILDs) : Preliminary Results
International Conference of the American Thoracic Society (ATS) 2022 ; May 13-18, 2022, San Francisco, CA, USA,In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 205 (2022) Nr. Supplement, A3922Online Volltext: dx.doi.org/ -
Effects of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Varying Severities of Cough
International Conference of the American Thoracic Society (ATS) 2021 ; May 14-19, 2021, Virtual,In: American Journal of Respiratory and Critical Care Medicine (AJRCCM) Jg. 203 (2021) Nr. 9, Supplement, A1903Online Volltext: dx.doi.org/ (Open Access)